Title: Mutation analysis of the tumor suppressor gene PPP2R1B in human cervical cancer
Authors: Yeh, L.-S.
Hsieh, Y.-Y.
Chang, J.-G.
Chang, W. W.-C.
Chang, C.-C.
Tsai, F.-J.
Department of Biological Science and Technology
Keywords: cervical cancer;loss of heterozygosity;PPP2R1B;protein phosphatase 2A;tumor suppressor gene
Issue Date: 1-Jul-2007
Abstract: Protein phosphatase 2A (PP2A) holoenzyme plays a critical role in cell cycle control and growth factor signaling. The PPP2R1B gene encodes the beta isoforms of the subunit A of the PP2A. We aimed to evaluate the role of the PPP2R1B gene in the pathogenesis of cervical cancer. Twenty-four women with primary cervical cancer were included. All resected specimens were divided into two groups: (1) cervical cancers (n = 24), (2) nearby noncancerous tissues (n = 24). We performed nested reverse transcriptase-polymerase chain reaction analysis and complementary DNA sequencing on the genomic DNA samples of all specimens. The aberrant transcripts and gene mutation as well as the genotype and allele frequencies of codon 66 CTA/CTG of PPP2R1B genes in both groups were compared. The percentages of aberrant transcripts between both groups were nonsignificantly different (20.8% vs 33.3%). There was no mutation in all specimens. The genotype and allele frequencies between both groups were non-different. Proportions of CTA homozygote/heterozygote/CTG homozygote were (1) 66.7/8.3/25% and (2) 58.3/12.5/29.2%. Proportions of CTA/CTG alleles in both groups were (1) 70.8/29.2% and (2) 64.6/35.4%. We conclude that PPP2R1B genes may not play a role in the carcinogenesis of cervical cancer. Mutations of PPP2R1B gene are not frequent in cervical cancer.
URI: http://dx.doi.org/10.1111/j.1525-1438.2007.00880.x
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2007.00880.x
Volume: 17
Issue: 4
Begin Page: 868
End Page: 871
Appears in Collections:Articles